Roberto Chiarle

34PUBLICATIONS
201CO-AUTHORS
Tumour immunologyMolecular targetsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 28, 2026
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Mar 21, 2026
Author Correction: Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Matteo Menotti, Chiara Ambrogio, Taek-Chin Cheong

|Jan 30, 2026
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic Leukemia.

Chiara Pighi, Alessandro Gasparetto, Elisa Genuardi

|Dec 24, 2025
Exportin 1 as a Therapeutic Target to Overcome Drug Resistance in Lung Cancer.

Maria Vittoria Di Marco, Alessandro Gasparetto, Roberto Chiarle

|Oct 08, 2025
CAR-ving a Path: Metalloprotease-Engineered CAR T Cells Tunnel through Solid Tumors.

Alessandro Gasparetto, Roberto Chiarle

Pageof 6

Frequent Collaborators

11 joint publications

Claudia Voena

9 joint publications

Chiara Ambrogio

7 joint publications

Taek-Chin Cheong

4 joint publications

Rafael B Blasco